Targiniq

Targiniq is an oral medication combining oxycodone and naloxone for pain relief. It is designed to manage moderate to severe pain while reducing opioid-induced constipation. This combination helps balance pain control with gastrointestinal comfort. Suitable for adults requiring continuous opioid therapy.

Targiniq is used for managing moderate to severe pain in adults who need continuous opioid treatment. It combines oxycodone, a strong pain reliever, with naloxone to help reduce constipation often caused by opioids. This combination is particularly useful for patients requiring long-term pain management while maintaining digestive comfort.

Targiniq provides effective pain relief by acting on the central nervous system to reduce pain perception. The naloxone component helps counteract opioid-related bowel issues, promoting better digestive function. Users may experience improved pain control with fewer gastrointestinal side effects compared to traditional opioid therapies.

Targiniq should be stored in a secure, dry place away from children and pets. It is important to follow the prescribed dosage and avoid alcohol or other sedatives while taking this medication. Patients should inform their healthcare provider about any existing medical conditions or medications they are currently using.

Targiniq may interact with other central nervous system depressants, such as alcohol, benzodiazepines, or sleep medications, increasing the risk of drowsiness or respiratory depression. It can also interact with CYP3A4 inhibitors or inducers, which may affect its metabolism. Always consult a healthcare provider before combining medications.